P3 Health Partners (NASDAQ:PIII – Get Free Report) is projected to release its Q2 2025 earnings data after the market closes on Thursday, August 14th. Analysts expect P3 Health Partners to post earnings of ($3.29) per share and revenue of $356.52 million for the quarter.
P3 Health Partners (NASDAQ:PIII – Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported ($6.28) earnings per share for the quarter, missing the consensus estimate of ($5.00) by ($1.28). P3 Health Partners had a negative net margin of 9.27% and a negative return on equity of 123.10%. The business had revenue of $373.23 million during the quarter, compared to analysts’ expectations of $362.09 million. On average, analysts expect P3 Health Partners to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
P3 Health Partners Price Performance
Shares of P3 Health Partners stock opened at $6.74 on Tuesday. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 1.68. P3 Health Partners has a twelve month low of $5.80 and a twelve month high of $31.50. The business has a 50-day moving average price of $6.57 and a 200 day moving average price of $8.15. The firm has a market cap of $48.46 million, a PE ratio of -0.14 and a beta of 0.81.
Wall Street Analyst Weigh In
View Our Latest Stock Report on P3 Health Partners
P3 Health Partners Company Profile
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
See Also
- Five stocks we like better than P3 Health Partners
- Most active stocks: Dollar volume vs share volume
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- How to Calculate Options Profits
- IPO Market Stays Hot With These 2 Debuting Stocks
- Differences Between Momentum Investing and Long Term Investing
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.